TCb vs EC-T in High Risk ER+/HER2- Breast Cancer
TCb vs EC-T in High Risk ER+/HER2- Breast Cancer
Recruiting · NCT05901428 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TCb vs EC-T in High Risk ER+/HER2- Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Recruiting | Phase 3 | 2026-09-28 | NCT05901428 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Breast cancer institute of Fudan University Cancer Hospital | Shanghai | China | 16 |